# EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
> **ANDA090437** · Abbreviated New Drug Application (Generic) · Sponsor: MATRIX LABS LTD · Approved 2009-08-12
## Drug
- **FDA Application Number:** ANDA090437
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
- **Generic name:** Efavirenz
- **Active ingredients:** EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MATRIX LABS LTD
- **First approval:** 2009-08-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090437)
---
*AI Analytics · CC0 1.0*